Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Odpredpisovanje zaviralcev protonske črpalke
Authors:ID Nastran Možina, Mojca (Author)
ID Japelj, Nuša (Author)
Files:.pdf PDF - Presentation file, download (274,97 KB)
MD5: 1852059147036992458066D1BFEC16F3
 
Language:Slovenian
Typology:1.04 - Professional Article
Organization:Logo SFD - Slovenian Pharmaceutical Society
Abstract:Zdravljenje z zaviralci protonske črpalke je pogosto neskladno s smernicami, velikokrat so namreč predpisani brez jasne indikacije, v predolgem trajanju ali v previsokih odmerkih. To povečuje breme zdravljenja z zdravili, tveganje za neželene učinke in klinično pomembne interakcije. Pri bolnikih z neustrezno predpisanim zaviralcem protonske črpalke je zato utemeljena ukinitev ali znižanje odmerka v okviru načrtovanega in nadzorovanega procesa odpredpisovanja. Prispevek povzema ključne smernice in strokovna priporočila za odpredpisovanje zaviralcev protonske črpalke ter z dvema kliničnima primeroma ponazori praktično izvedbo tega procesa.
Keywords:klinični primeri, neželeni učinki zdravil, odpredpisovanje, polifarmakoterapija, zaviralci protonske črpalke
Publication status:Published
Publication version:Version of Record
Publication date:01.05.2026
Year of publishing:2026
Number of pages:str. 162-167
Numbering:Letn. 77, št. 2
PID:20.500.12556/DiRROS-31047 New window
UDC:615.33:616-085
ISSN on article:2536-4316
COBISS.SI-ID:280592131 New window
Note:Opis vira z dne 5. 6. 2026; Nasl. z nasl. zaslona;
Publication date in DiRROS:10.07.2026
Views:127
Downloads:58
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Farmacevtski vestnik : strokovno glasilo slovenske farmacije
Publisher:Slovensko farmacevtsko društvo
ISSN:2536-4316
COBISS.SI-ID:288686336 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Licensing start date:01.01.2025

Secondary language

Language:English
Title:klinična primera
Abstract:Treatment with proton pump inhibitors is frequently inconsistent with clinical guidelines, as these medicines are often prescribed without a clear indication, for prolonged periods, or at excessively high doses. This increases the medication burden, the risk of adverse effects, and clinically significant drug–drug interactions. In patients with inappropriately prescribed proton pump inhibitors, discontinuation or dose reduction within a planned and supervised deprescribing process is therefore warranted. This article summarizes guidelines and expert recommendations for proton pump inhibitors deprescribing and illustrates their practical implementation through two clinical cases.
Keywords:adverse drug reactions, case reports, deprescribing, polypharmacy, proton pump inhibitors


Back